Skip to Main Content
Table 1

Outcomes of CSII during 9-year follow-up

Duration of insulin pump therapy (years)
123456789
Number of patients 161 122 105 85 70 57 37 23 17 
Decrease in HbA1c from baseline (% [mmol/mol]) −1.3 ± 1.8 (14.2 ± 19.7) −1.3 ± 1.9 (14.2 ± 20.8) −1.3 ± 1.7 (14.2 ± 18.6) −1.4 ± 2.0 (15.3 ± 21.9) −1.5 ± 1.9 (16.4 ± 20.8) −1.0 ± 2.0 (10.9 ± 21.9) −1.6 ± 2.0 (17.5 ± 21.9) −1.5 ± 2.1 (16.4 ± 23.0) −1.4 ± 2.1 (15.3 ± 23.0) 
Mean increase in weight from baseline (kg) 2.9 ± 7.6 3.7 ± 8.1 3.8 ± 8.9 4.8 ± 9.8 4.0 ± 10.9 6.1 ± 11.0 2.9 ± 10.4 8.7 ± 10.1 7.6 ± 11.0 
Total daily insulin dose (units/kg/day) 1.01 ± 0.54 0.97 ± 0.55 0.98 ± 0.48 1 ± 0.48 0.96 ± 0.47 1.18 ± 0.49 1.19 ± 0.78 1.19 ± 0.49 1.16 ± 0.6 
Cumulative number of deaths 10 11 13 14 15 
Cumulative number of pump arrests 12 29 22 22 25 25 27 27 
Cumulative number of patients lost to follow-up 
Duration of insulin pump therapy (years)
123456789
Number of patients 161 122 105 85 70 57 37 23 17 
Decrease in HbA1c from baseline (% [mmol/mol]) −1.3 ± 1.8 (14.2 ± 19.7) −1.3 ± 1.9 (14.2 ± 20.8) −1.3 ± 1.7 (14.2 ± 18.6) −1.4 ± 2.0 (15.3 ± 21.9) −1.5 ± 1.9 (16.4 ± 20.8) −1.0 ± 2.0 (10.9 ± 21.9) −1.6 ± 2.0 (17.5 ± 21.9) −1.5 ± 2.1 (16.4 ± 23.0) −1.4 ± 2.1 (15.3 ± 23.0) 
Mean increase in weight from baseline (kg) 2.9 ± 7.6 3.7 ± 8.1 3.8 ± 8.9 4.8 ± 9.8 4.0 ± 10.9 6.1 ± 11.0 2.9 ± 10.4 8.7 ± 10.1 7.6 ± 11.0 
Total daily insulin dose (units/kg/day) 1.01 ± 0.54 0.97 ± 0.55 0.98 ± 0.48 1 ± 0.48 0.96 ± 0.47 1.18 ± 0.49 1.19 ± 0.78 1.19 ± 0.49 1.16 ± 0.6 
Cumulative number of deaths 10 11 13 14 15 
Cumulative number of pump arrests 12 29 22 22 25 25 27 27 
Cumulative number of patients lost to follow-up 

Data are mean ± SD unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal